Prof. Valmed® / Press & science
Research on Prof. Valmed®, regulatory announcements and news from our partners.
01 / Scientific literature
Selected publications evaluating Prof. Valmed®. Each study has its own methods, setting and limitations. Read the original work for the complete findings and disclosures.
Kirschner et al. · Evaluating the First CE-Marked LLM-Based Chatbot for Evidence-Based Neurology
Evaluation using 130 guideline-based questions across neurological topics. Findings concern the tested product version and question set; they do not establish clinical outcome benefits.
Read the publication ↗Kremer et al. · Comparative evaluation of Prof. Valmed®, ChatGPT-5 Thinking and OpenEvidence
A comparison using 60 complex rheumatology vignettes. No statistically significant pairwise differences were found. Vignette performance is distinct from performance in routine care.
Read the publication ↗Inojosa et al. · Education Research: Can Large Language Models Match MS Specialist Training?
A comparison of AI and student responses to multiple-choice and open-ended questions. The study examines an educational setting, not prospective patient outcomes.
Read the publication ↗Research results relate to specific versions and evaluation settings. CE marking establishes regulatory conformity; it is not a claim of superior performance against other systems.
02 / Press & updates
Company releases and announcements from ecosystem partners, labelled by source.
Telekom announces its collaboration with Prof. Valmed® for certified AI support in healthcare.
Telekom newsroom ↗The partnership brings medical decision support into hospital workflows.
Read the press release (PDF, German) ↗Prof. Valmed® joins the SAP ecosystem. Explore the product listing and integration context.
View SAP product listing ↗VDE reports on the Class IIb certification of the medical AI copilot and its regulatory development.
VDE announcement (German) ↗Media & research enquiries
For interviews, background information and scientific collaboration.